By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ferrer Internacional 

Edifici L'illa
Diagonal, 549 5ª planta
Barcelona    E-08029  Spain
Phone: 34-93-600-3700 Fax: 34-93-490-7078


Medical Device

Company News
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Expand ADASUVE┬« Partnership 10/27/2014 8:27:58 AM
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Provide Update On ADASUVE┬« European Commercial Activities 9/19/2014 7:21:03 AM
Ferrer Internacional Licenses Commercialisation Rights For Ozenoxacin In The United States To Medimetriks Pharmaceuticals, Inc. 3/24/2014 11:39:24 AM
Alexza Pharmaceuticals, Inc. (ALXA) And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania 3/14/2014 10:31:42 AM
Ferrer Internacional To Develop Lorediplon For Insomnia With Ildong Pharmaceuticals And ErgoMed Clinical Research 2/3/2014 9:04:16 AM
Partnership Between AOP Orphan Pharmaceuticals AG and Ferrer Internacional: Joint Marketing of Adasuve® in CEE 10/29/2013 8:45:51 AM
Ferrer Internacional and Medivir AB (MVIRb.F) Enter Agreement for Commercializing a New Treatment for Agitation Associated With Schizophrenia and Bipolar Disease in the Nordics 9/18/2013 10:10:21 AM
Ferrer Internacional Successfully Completes a Phase III Clinical Trial in Adult and Paediatric Patients With Impetigo for Novel Antibacterial Compound Ozenoxacin 6/12/2013 9:11:17 AM
Grupo Ferrer Internacional S.A. Successfully Completes an Absorption, Tolerability and Safety Study in Juveniles as Young as Two Months of Age for Novel Antibacterial Compound Ozenoxacin 10/5/2012 11:00:15 AM
Ferrer Internacional Initiates Phase III Clinical Studies for Novel Antibacterial Compound, Ozenoxacin, in Development as a Topical Treatment for Impetigo and Other Infectious Dermatological Conditions 1/19/2012 10:27:03 AM